NCoA-3 Antibody (YA4985)

Cat. No.: HY-P85293: Data Sheet User Guide for Antibodies
FAQs
Technical Support

NCoA-3 Antibody (YA4985) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to NCoA-3.

For research use only. We do not sell to patients.

Size		Stock
50 μL		Get quote
100 μL		Get quote

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

NCoA-3 Antibody (YA4985) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to NCoA-3.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 155 kDa;

Observed band size: 155 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human

SwissProt ID

Q9Y6Q9

Gene ID

8202 [NCBI]

Immunogen

Purified recombinant fragment of human AIB1 expressed in E. Coli. The exact sequence is proprietary to MCE.

Application &
Dilution Ratio

Application	Dilution Ratio
WB WB: Western Blot	1:500-1:1000

Sensitivity	Endogenous	Purity	Ascitic Fluid
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in purified antibody in PBS with 0.05% sodium azide.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase activity. Also involved in the coactivation of the NF-kappa-B pathway via its interaction with the NFKB1 subunit

Subcellular Localization：Cytoplasm; Nucleus

Expression：
Tissue_specificity:Widely expressed. Highly expressed in the heart, skeletal muscle, pancreas, and placenta. Lowly expressed in the brain, and extremely lowly expressed in the lungs, liver, and kidneys.

Isoforms & Post-Translational Modification：Q9Y6Q9 has 5 isomers: Q9Y6Q9-1: 155293 Da (predicted); Q9Y6Q9-2: 153797 Da (predicted); Q9Y6Q9-3: 154400 Da (predicted); Q9Y6Q9-4: 147499 Da (predicted); Q9Y6Q9-5: 154892 Da (predicted).
Acetylated by CREBBP. Acetylation occurs in the RID domain, and disrupts the interaction with nuclear receptors and regulates its function;Methylated by CARM1;Phosphorylated by IKK complex. Regulated its function. Phosphorylation at Ser-601 by CK1 promotes coactivator function

Subunit：Present in a complex containing NCOA2, IKKA, IKKB, IKBKG and the histone acetyltransferase protein CREBBP (PubMed:11971985, PubMed:9346901).

Synonyms

NCOA3; AIB1; BHLHE42; RAC3; TRAM1; Nuclear receptor coactivator 3; NCoA-3; ACTR; Amplified in breast cancer 1 protein; AIB-1; CBP-interacting protein; pCIP; Class E basic helix-loop-helix protein 42; bHLHe42; Receptor-associated coactivator

Documentation

User Guide for Antibodies (1077 KB)